Active Funding Opportunity Announcements (FOAs) for All NICHD

NICHD issues and participates in various FOAs to support research activities and training.

Investigator-Initiated (Unsolicited) Projects

To submit unsolicited or investigator-initiated applications, use the appropriate NIH Parent Announcement.

Active FOAs for NICHD

Announcement Number Submissions Date(s) Expiration Date Activity Code(s) Title
PA-16-314 Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. September 8, 2019 R01 Characterization of the Adolescent Reproductive Transition (R01)
PA-16-315 Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. September 8, 2019 R21 Characterization of the Adolescent Reproductive Transition (R21)
PA-16-316 Standard dates apply), by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. September 8, 2019 R03 Characterization of the Adolescent Reproductive Transition (R03)
PA-16-444 Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. January 8, 2020 R21 Trophoblast Differentiation and Function (R21)
PA-16-445 Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. January 8, 2020 R01 Trophoblast Differentiation and Function (R01)
PA-17-085 Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. January 8, 2020 R21 Zika Virus (ZIKV) Complications (R21)
PA-17-091 Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

The first standard application due date for this FOA is June 5, 2017.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
May 8, 2020 R01 Fertility Status as a Marker for Overall Health (R01)
PA-17-092 Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

The first standard application due date for this FOA is June 16, 2017.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
May 8, 2020 R21 Fertility Status as a Marker for Overall Health (R21)
PA-17-259 Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
May 8, 2020 R21 NICHD Exploratory/Developmental Research Grant (R21)
PA-17-262 Standard AIDS dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on . September 8, 2020 R01 Promoting NICHD Areas of Research for HIV/AIDS in Maternal and Child Health (R01)
PA-17-299 Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. May 8, 2020 R03 Small Grants for Secondary Analyses of Existing Data Sets and Stored Biospecimens (R03)
PA-17-451 Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. September 8, 2020 R03 Pregnancy in Women with Disabilities (R03)
PA-17-452 Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. September 8, 2020 R01 Pregnancy in Women with Disabilities (R01)
PA-17-477 Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. The first standard due date for this FOA is February 16, 2018 January 8, 2021 R21 Research on Transgender Health (R21)
PA-17-478 Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.The first standard due date for this FOA is February 5, 2018 January 8, 2021 R01 Research on Transgender Health (R01)
PAR-15-285 Multiple dates, see announcement. January 8, 2018 R01 Bioengineering Research Partnership (BRP): Non- or Minimally-Invasive Methods to Measure Biochemical Substances during Neonatal and Perinatal Patient Care and Research (R01)
PAR-15-286 December 15, 2015; December 15, 2016; December 15, 2017, by 5:00 PM local time of applicant organization. December 16, 2017 X02 Pre-application: Opportunities for Collaborative Research at the NIH Clinical Center (X02)
PAR-15-287 April 11, 2016; April 11, 2017; April 11, 2018, by 5:00 PM local time of applicant organization. April 12, 2018 U01 Opportunities for Collaborative Research at the NIH Clinical Center (U01)
PAR-16-061 Multiple dates, see announcement. May 9, 2019 R01 Natural History of Disorders Identifiable by Screening of Newborns (R01)
PAR-16-114 June 5, 2016; June 5, 2017; June 5, 2018, by 5:00 PM local time of applicant organization. June 6, 2018 R01 Spermatogenic Stem Cell Culture Systems to Preserve and Restore Reproductive Capacity in Males (R01)
top of pageBACK TO TOP